MedTrace Logo

Mobile Phone-Based Motivational Interviewing in Kenya

NCT03573167 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 322

Last updated 2018-06-29

No results posted yet for this study

Summary

The primary objective of this study was to test whether motivational interviewing (MI) provided over the mobile phone would reduce alcohol use among adults, including people living with HIV/AIDS, visiting primary care in Kenya. Heavy alcohol users voluntarily consented to being randomized to one of three study arms: standard in-person MI, mobile MI, or waitlist control receiving no intervention for 1 month followed by mobile MI. Alcohol use problems were assessed using validated screeners and changes in alcohol use were assessed at 1 month and 6 months after receiving the intervention. The investigators hypothesized that alcohol use would reduce after MI treatment compared to waitlist control, there would be no difference between standard in-person MI and mobile MI, and these reductions would be sustained out to six months following the intervention.

Conditions

Interventions

BEHAVIORAL

In-Person Motivational Interviewing (MI)

This is a counseling intervention to support behavior change conducted in-person (face-to-face) between the investigator and the participant.

BEHAVIORAL

Mobile Motivational Interviewing (MI)

This is a counseling intervention to support behavior change conducted entirely over the mobile phone between the investigator and the participant

Sponsors & Collaborators

  • Africa Institute of Mental and Brain Health (AFRIMEB)

    collaborator OTHER

  • University of Vermont

    lead OTHER

Principal Investigators

  • Valerie Harder, PhD · University of Vermont

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-12-31
Completion
2015-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03573167 on ClinicalTrials.gov